Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -1.19%320.05M | -11.12%1.19B | -3.77%949.52M | -5.97%639.28M | -3.44%323.89M | 10.58%1.34B | 14.57%986.68M | 22.82%679.86M | 19.35%335.42M | 14.56%1.21B |
Refunds of taxes and levies | 5,430.78%209.97K | -48.97%171.37K | -99.01%105K | -95.95%88.99K | -97.00%3.8K | -97.85%335.82K | -33.28%10.55M | -85.80%2.2M | 9,891.09%126.44K | 4,500.75%15.6M |
Cash received relating to other operating activities | -62.20%9.98M | 434.52%105.84M | 11.27%45.23M | 35.07%31.74M | 624.47%26.41M | -59.53%19.8M | -12.32%40.65M | -47.97%23.5M | -85.97%3.65M | -6.52%48.93M |
Cash inflows from operating activities | -5.73%330.24M | -4.63%1.3B | -4.15%994.86M | -4.88%671.11M | 3.28%350.3M | 6.56%1.36B | 12.40%1.04B | 14.88%705.55M | 10.48%339.19M | 14.93%1.27B |
Goods services cash paid | 91.78%42.95M | -32.11%134.14M | -25.66%73.99M | -24.66%51.23M | -2.61%22.39M | -0.35%197.58M | -18.95%99.53M | -27.61%68M | -42.64%22.99M | 64.56%198.27M |
Staff behalf paid | 15.10%56.13M | 6.41%170.12M | 6.82%131.02M | 7.13%90.29M | 8.18%48.77M | 19.66%159.88M | 22.49%122.65M | 22.83%84.28M | 20.36%45.08M | 35.61%133.61M |
All taxes paid | -1.76%28.28M | 2.87%198.71M | 22.89%148.28M | 12.03%83.55M | 6.40%28.79M | 15.13%193.16M | 17.62%120.66M | 17.91%74.58M | 21.86%27.05M | 25.99%167.78M |
Cash paid relating to other operating activities | -15.92%161.36M | 9.62%649.99M | 8.79%579.9M | 8.14%406M | 8.01%191.91M | -4.23%592.96M | 2.27%533.05M | 0.08%375.45M | -7.84%177.69M | -3.56%619.14M |
Cash outflows from operating activities | -1.08%288.72M | 0.82%1.15B | 6.54%933.2M | 4.78%631.07M | 6.98%291.86M | 2.22%1.14B | 3.44%875.9M | 0.22%602.31M | -6.74%272.82M | 12.54%1.12B |
Net cash flows from operating activities | -28.96%41.52M | -33.68%142.23M | -61.93%61.66M | -61.22%40.04M | -11.94%58.44M | 37.78%214.44M | 111.34%161.99M | 683.35%103.25M | 359.15%66.37M | 35.67%155.65M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 306.67%183M | -84.21%240.54M | -92.54%95M | -95.03%50M | -92.12%45M | -24.10%1.52B | -15.61%1.27B | -10.73%1.01B | 5.74%571M | 199.02%2.01B |
Cash received from returns on investments | 3,316.30%1.91M | -97.72%235.96K | -98.31%93.51K | -98.68%59.12K | -98.09%56.05K | -18.60%10.37M | -48.32%5.52M | -42.55%4.49M | -29.05%2.94M | 198.69%12.74M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -54.59%23.03K | -87.42%4.3K | -87.42%4.3K | ---- | -58.37%50.71K | -68.65%34.19K | -43.91%34.19K | -36.53%14.28K | -5.29%121.83K |
Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --70.92K |
Cash inflows from investing activities | 310.41%184.91M | -84.30%240.79M | -92.56%95.1M | -95.05%50.06M | -92.15%45.06M | -24.07%1.53B | -15.84%1.28B | -10.95%1.01B | 5.46%573.95M | 198.99%2.02B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 144.86%99.25M | 121.12%233.87M | 71.12%111.44M | 81.97%79.19M | 58.74%40.53M | -19.78%105.76M | -11.41%65.12M | -1.46%43.52M | -3.27%25.53M | 43.16%131.85M |
Cash paid to acquire investments | 1,856.89%210.2M | -73.66%365.74M | -72.91%382.74M | -87.68%140.74M | -97.74%10.74M | -34.45%1.39B | -1.23%1.41B | 10.80%1.14B | -13.14%476M | 92.47%2.12B |
Cash outflows from investing activities | 503.51%309.45M | -59.88%599.61M | -66.57%494.18M | -81.45%219.94M | -89.78%51.27M | -33.59%1.49B | -1.73%1.48B | 10.29%1.19B | -12.69%501.53M | 88.66%2.25B |
Net cash flows from investing activities | -1,902.58%-124.53M | -1,017.17%-358.82M | -99.58%-399.08M | 2.37%-169.87M | -108.59%-6.22M | 116.96%39.12M | -1,463.84%-199.96M | -384.84%-174M | 340.07%72.42M | 55.42%-230.62M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --9.97M | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --9.97M | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
Cash from borrowing | -31.19%20.53M | 488.16%100.61M | --73.7M | --52.75M | --29.84M | --17.11M | ---- | ---- | ---- | ---- |
Cash received relating to other financing activities | ---- | ---- | -92.65%1.12M | ---- | ---- | -11.80%15.19M | 73.12%15.19M | --10.05M | ---- | --17.22M |
Cash inflows from financing activities | 2.24%30.51M | 202.20%100.61M | 392.64%74.82M | 424.87%52.75M | --29.84M | 93.36%33.29M | 73.12%15.19M | --10.05M | ---- | -97.45%17.22M |
Dividend interest payment | 178.48%672.53K | 2.26%86.35M | --1.25M | --657.64K | --241.5K | 28.61%84.44M | ---- | ---- | ---- | --65.66M |
Cash payments relating to other financing activities | ---- | ---- | ---- | ---- | ---- | -77.37%6.32M | -63.30%6.32M | --6.32M | --5.44M | 52.09%27.93M |
Cash outflows from financing activities | 178.48%672.53K | -4.86%86.35M | -80.14%1.25M | -89.59%657.64K | -95.56%241.5K | -3.02%90.76M | -92.37%6.32M | -90.37%6.32M | --5.44M | 409.62%93.59M |
Net cash flows from financing activities | 0.80%29.83M | 124.82%14.26M | 729.61%73.57M | 1,296.56%52.09M | 644.32%29.6M | 24.75%-57.47M | 111.97%8.87M | 105.68%3.73M | ---5.44M | -111.65%-76.37M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -217.64%-45.42K | 5,173.71%424.1K | -205.21%-338.05K | -62.81%160.26K | 124.46%38.61K | -98.48%8.04K | -58.85%321.32K | 165.18%430.97K | -858.12%-157.8K | 1,630.63%528.11K |
Net increase in cash and cash equivalents | -165.02%-53.23M | -202.96%-201.91M | -817.68%-264.19M | -16.51%-77.58M | -38.54%81.86M | 230.03%196.11M | -260.08%-28.79M | -859.45%-66.59M | 946.93%133.19M | -159.60%-150.82M |
Add:Begin period cash and cash equivalents | -53.51%175.44M | 108.20%377.35M | 108.20%377.35M | 108.20%377.35M | 108.20%377.35M | -45.42%181.24M | -45.42%181.24M | -45.42%181.24M | -45.42%181.24M | 320.22%332.06M |
End period cash equivalent | -73.39%122.21M | -53.51%175.44M | -25.78%113.15M | 161.46%299.76M | 46.04%459.21M | 108.20%377.35M | -56.45%152.45M | -66.36%114.65M | -0.60%314.43M | -45.42%181.24M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.